Valuation: Amgen Inc.

Market Cap 249B 223B 205B 186B 349B 23,622B 358B 2,443B 983B 12,468B 936B 916B 39,518B P/E 2026 *
28.9x
P/E 2027 * 25.8x
Enterprise Value 289B 258B 237B 215B 404B 27,352B 414B 2,828B 1,138B 14,436B 1,084B 1,061B 45,757B EV / Sales 2026 *
7.35x
EV / Sales 2027 * 7x
Free-Float
99.77%
Yield 2026 *
2.19%
Yield 2027 * 2.31%
1 day-0.90%
1 week+2.97%
Current month-1.02%
1 month+14.45%
3 months+21.75%
6 months+39.85%
Current year+40.92%
1 week 457.36
Extreme 457.355
475.64
1 month 396.01
Extreme 396.01
475.64
Current year 318.21
Extreme 318.21
475.64
1 year 302.13
Extreme 302.13
475.64
3 years 253.3
Extreme 253.3
475.64
5 years 198.64
Extreme 198.64
475.64
10 years 137.16
Extreme 137.16
475.64
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Chief Tech/Sci/R&D Officer 57 2023-05-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Other

Chief Financial Officer

34,061 0.0063%
8/13/26 Exercice

Executive/Senior Manager

3,756 0.0007%
8/7/26 Free

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%+2.97%+55.67%+70.93% 249B
-0.11%+9.94%+57.20%+148.21% 1,255B
-1.62%-0.95%+42.90%+75.88% 641B
-0.98%-0.14%+34.93%+102.23% 505B
+0.75%-1.38%+48.98%+65.84% 381B
-2.49%+2.01%+75.38%+39.94% 357B
+1.62%+3.22%+31.43%+58.33% 303B
+1.61%+9.32%+11.38%+35.79% 286B
-1.68%+5.27%+37.21%+105.26% 208B
+4.42%+10.14%-10.90%-59.94% 179B
Average +2.20%+3.06%+38.42%+64.25% 436.38B
Weighted average by Cap. +2.23%+3.91%+44.67%+87.63%

Financials

2026 *2027 *
Net sales 39.29B 35.1B 32.24B 29.28B 54.99B 3,722B 56.37B 385B 155B 1,964B 147B 144B 6,226B 40.61B 36.28B 33.32B 30.26B 56.83B 3,846B 58.26B 398B 160B 2,030B 152B 149B 6,435B
Net income 8.55B 7.64B 7.02B 6.37B 11.97B 810B 12.27B 83.76B 33.69B 428B 32.09B 31.41B 1,355B 9.44B 8.43B 7.75B 7.03B 13.21B 894B 13.54B 92.46B 37.19B 472B 35.43B 34.67B 1,496B
Net Debt 39.37B 35.17B 32.31B 29.34B 55.11B 3,730B 56.49B 386B 155B 1,968B 148B 145B 6,239B 34.79B 31.08B 28.55B 25.93B 48.69B 3,295B 49.91B 341B 137B 1,739B 131B 128B 5,513B
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-11-03 $461.26 -0.90% 2,381,953
26-11-02 $465.45 -0.12% 3,196,517
26-10-30 $466.01 +1.15% 3,290,626
26-10-29 $460.73 +1.97% 2,982,878
26-10-28 $451.83 +0.87% 2,912,150
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
461.26USD
Average target price
404.32USD
Spread / Average Target
-12.34%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.
  1. Stock Market
  2. Stocks
  3. AMGN Stock